Research Projects
Ongoing
  • April 2024 - March 2026

    Phase 1 Clinical Development of Treatment Modalities for SARS-CoV-2 Infection and Related Complications’ sanctioned by DBT-BIRAC under COVID-Suraksha Scheme (Co-PI)

    Total Outlay Rs. 420.20 lakh
  • May 2022 - March 2025
    Crocetin Bio-production in Microalgae

    A Novel Route to Oxygen Diffusion Enhancing Phytochemical and Its Semisynthetic Analogues (SERB/POWER Grant)

    Total Outlay Rs.29,60,000
  • March 2021 – March 2025
    SWASHRAY (Self-Reliance in Working Around Sustainable, Helpful, Reliable and High-Yielding Processes and Technologies)

    Department of Science and Technology (DST) under the scheme ‘Promotion of University Research and Scientific Excellence (PURSE)’ – 2020 (Sanction Letter SR/PURSE/2020/8, dated 15th February 2021

    Total Outlay: Rs.26,00,00,000

Completed
  • June 2022 – March 2023

    Study of the Impact of CaCO3 and Iron Oxide on Light Transmission through Empty Hard Capsule Shells, sponsored by ACG Associated Capsules, Mumbai (PI)

    Total Outlay Rs.1,20,000
  • April 2022 - August 2022

    Deformulation of a Herbicide Product sponsored by Brizo Services Pvt. Ltd., Navi Mumbai (PI)

    Total Outlay Rs.1,62,000
  • March 2016 – August 2017
    Targeting Therapy-resistant Cancer Stem Cells (BIPP/BIRAC/DBT)

    Collaborator - Along with Godavari Biorefineries Ltd., Mumbai

    Total Outlay Rs.1,50,00,000
  • May 2014 - May 2017
    Design and Development of Novel Inhibitors of Inosine 5’

    Monophosphate Dehydrogenase II (IMPDH II) as Anti-inflammatory Agents (DST/SERB) (Sanction Order No. SERB/F/60/2014-15 dated 09.04.2014)

    Total Outlay: Rs.26,00,000
  • September 2012 - August 2015
    Discovery of Inhibitors of System Xc¯ Transporter

    A Novel Therapeutic Target for Glutamate-Mediated Excitoxicity and Epileptogenesis (DBT/NTF) (Reference No. BT/PR4605/MED/30/719/2012

    Total Outlay: Rs.18,16,000
  • September 2018 - November 2018
    Synthesis of New Chemical Entities (NCEs) (SpargeChem Pvt. Ltd., Pune)
    Total Outlay: Rs.1,20,000
  • January 2018 - April 2018
    Evaluation of XARTM for Anti-Aging Effects (Epigeneres Pvt. Ltd., Mumbai)
    Total Outlay: Rs.40,000
  • January 2018 – March 2018
    Scale-up of Lead Anti-Cancer Stem Cell Molecule Intermediate (Godavari Biorefineries Ltd., Mumbai)
    Total Outlay: Rs.1,00,000
  • October 2017 - December 2017
    Evaluation of XARTM for the Treatment of Polycystic Ovarian Syndrome using a Mice as an Animal Model (Epigeneres Pvt. Ltd., Mumbai)

    Development of Novel

    Total Outlay: Rs.50,000
  • November 2016 - October 2019
    Fluorescent Substrates for Enzyme Sensitive Assays of Aminoacylases, Trypsin and Chymotrypsin (SVKM’s NMIMS)
    Total Outlay: Rs.1,00,000
  • February 2015 – April 2015
    Comparative Evaluation of Microcrystalline Cellulose obtained from Bagasse (MCC-B) with Pharmaceutical Grade MCC

    Consultancy Project sponsored by Godavari Biorefineries Ltd., Mumbai

    Total Outlay: Rs.1,00,000